Letters sent to healthcare professionals in March 2017

A summary of letters sent to relevant healthcare professionals.

In March 2017, the following letter was sent to relevant healthcare professionals to inform them of updated safety information:

  • Nulojix (belatacept) 250 mg: supply shortage—restricted to existing patients

We are also aware of the following letter, which was sent to relevant healthcare professionals in October 2016:

Article citation: Drug Safety Update volume 10, issue 9, April 2017: 4.

Published 24 April 2017